Colorectal cancer screening: prospects for molecular stool analysis

[1]  P Glasziou,et al.  Screening for colorectal cancer using the faecal occult blood test, Hemoccult. , 2007, The Cochrane database of systematic reviews.

[2]  G. Friedman,et al.  Screening sigmoidoscopy and colorectal cancer mortality , 1990, Journal of General Internal Medicine.

[3]  Michael A. Gonzalez,et al.  Control of DNA replication and its potential clinical exploitation , 2005, Nature Reviews Cancer.

[4]  D. Ransohoff,et al.  Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. , 2004, The New England journal of medicine.

[5]  J. Issa.  CpG island methylator phenotype in cancer , 2004, Nature Reviews Cancer.

[6]  M. Vatn,et al.  Testing for faecal calprotectin (PhiCal) in the Norwegian Colorectal Cancer Prevention trial on flexible sigmoidoscopy screening: comparison with an immunochemical test for occult blood (FlexSure OBT) , 2004, Gut.

[7]  E. Eigenbrodt,et al.  Faecal tumour M2 pyruvate kinase: a new, sensitive screening tool for colorectal cancer , 2004, British Journal of Cancer.

[8]  R. Brand,et al.  Reproducibility of a Multitarget Stool-Based DNA Assay for Colorectal Cancer Detection , 2004, American Journal of Gastroenterology.

[9]  M. Burns,et al.  Case-Control Study , 2020, Definitions.

[10]  Michal Amitai,et al.  Actual Colonic Perforation in Virtual Colonoscopy: Report of a Case , 2004, Diseases of the colon and rectum.

[11]  L. P. Angel,et al.  Perforated Colon Secondary to Virtual Colonoscopy: Report of a Case , 2004, Diseases of the colon and rectum.

[12]  M. Widschwendter,et al.  Methylation changes in faecal DNA: a marker for colorectal cancer screening? , 2004, The Lancet.

[13]  P. Pickhardt,et al.  Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. , 2003, The New England journal of medicine.

[14]  T. Fujita,et al.  Testing of multiple samples increases the sensitivity of stool decay-accelerating factor test for the detection of colorectal cancer , 2003, American Journal of Gastroenterology.

[15]  Douglas W Mahoney,et al.  Prospective evaluation of fecal calprotectin as a screening biomarker for colorectal neoplasia , 2003, American Journal of Gastroenterology.

[16]  S. Cole,et al.  Prescreening Evaluation of a Brush-Based Faecal Immunochemical Test for Haemoglobin , 2003, Journal of medical screening.

[17]  S R Cole,et al.  A Randomised Trial of the Impact of New Faecal Haemoglobin Test Technologies on Population Participation in Screening for Colorectal Cancer , 2003, Journal of medical screening.

[18]  C. Johnson,et al.  Prospective blinded evaluation of computed tomographic colonography for screen detection of colorectal polyps. , 2003, Gastroenterology.

[19]  D. Ahlquist,et al.  DNA integrity as a potential marker for stool-based detection of colorectal cancer. , 2003, Clinical chemistry.

[20]  A. Munakata,et al.  Prevention of advanced colorectal cancer by screening using the immunochemical faecal occult blood test: a case–control study , 2003, British Journal of Cancer.

[21]  H. El‐Serag,et al.  Is There a True “shift” to the Right Colon in the Incidence of Colorectal Cancer? , 2003, American Journal of Gastroenterology.

[22]  M. Lawson,et al.  Sensitivity and specificity of a stool DNA multitarget assay panel for the detection of advanced colorectal neoplasia. , 2003, Clinical colorectal cancer.

[23]  J. Potter,et al.  Long-term efficacy of sigmoidoscopy in the reduction of colorectal cancer incidence. , 2003, Journal of the National Cancer Institute.

[24]  Peter Baldwin,et al.  Translational approaches to improving cervical screening , 2003, Nature Reviews Cancer.

[25]  S. Woolf,et al.  Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. , 2003, Gastroenterology.

[26]  Yonggoo Kim,et al.  Gastrointestinal tract cancer screening using fecal carcinoembryonic antigen. , 2003, Annals of clinical and laboratory science.

[27]  Marco A Pierotti,et al.  Tumor location and detection of k-ras mutations in stool from colorectal cancer patients. , 2003, Journal of the National Cancer Institute.

[28]  C. Crosta,et al.  Baseline findings of the Italian multicenter randomized controlled trial of "once-only sigmoidoscopy"--SCORE. , 2002, Journal of the National Cancer Institute.

[29]  Xinghua Lu,et al.  Detecting K-ras and p53 gene mutation from stool and pancreatic juice for diagnosis of early pancreatic cancer. , 2002, Chinese medical journal.

[30]  A. Sonnenberg,et al.  Continued Rightward Shift of Colorectal Cancer , 2002, Diseases of the colon and rectum.

[31]  S. Bingham,et al.  Analysis of minichromosome maintenance proteins as a novel method for detection of colorectal cancer in stool , 2002, The Lancet.

[32]  T. Vogl,et al.  Computer-aided diagnosis in contrast-enhanced CT colonography: an approach based on contrast , 2002, European Radiology.

[33]  M. Koshiji,et al.  Microsatellite analysis of fecal DNA for colorectal cancer detection * , 2002, Journal of surgical oncology.

[34]  J. Wardle,et al.  Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial , 2002, The Lancet.

[35]  S. Bingham,et al.  Isolation of exfoliated colonocytes from human stool as a new technique for colonic cytology , 2002, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[36]  K. Kinzler,et al.  Detection of proximal colorectal cancers through analysis of faecal DNA , 2002, The Lancet.

[37]  K. Kinzler,et al.  Detection of APC mutations in fecal DNA from patients with colorectal tumors. , 2002, The New England journal of medicine.

[38]  O. Kronborg,et al.  A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds , 2002, Gut.

[39]  D. Ahlquist,et al.  Stool screening for colorectal cancer: evolution from occult blood to molecular markers. , 2002, Clinica chimica acta; international journal of clinical chemistry.

[40]  Matty P. Weijenberg,et al.  A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer , 2002, Nature Genetics.

[41]  A. Hara,et al.  Detection of flat lesions in the colon with CT colonography , 2002, Abdominal Imaging.

[42]  P. Babb,et al.  Current trends in colorectal cancer: site, incidence, mortality and survival in England and Wales. , 2001, Clinical oncology (Royal College of Radiologists (Great Britain)).

[43]  F. Alexander,et al.  A demonstration pilot trial for colorectal cancer screening in the United Kingdom: a new concept in the introduction of healthcare strategies , 2001, Journal of medical screening.

[44]  D. Parkin,et al.  Global cancer statistics in the year 2000. , 2001, The Lancet. Oncology.

[45]  D. Lieberman,et al.  One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. , 2001, The New England journal of medicine.

[46]  J. Qu,et al.  [Telomerase activity in stool of patients with colorectal cancer]. , 2001, Zhonghua wai ke za zhi [Chinese journal of surgery].

[47]  S. Cole,et al.  Effect of dietary restriction on participation in faecal occult blood test screening for colorectal cancer , 2001, The Medical journal of Australia.

[48]  N. B. Atkin.  Microsatellite instability , 2001, Cytogenetic and Genome Research.

[49]  S. Goodman,et al.  Detecting colorectal cancer in stool with the use of multiple genetic targets. , 2001, Journal of the National Cancer Institute.

[50]  R. Capocaccia,et al.  Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence , 2001, Gut.

[51]  F. Kee,et al.  Flexible sigmoidoscopy and the changing distribution of colorectal cancer: implications for screening , 2001, Gut.

[52]  W F Bodmer,et al.  The ABC of APC. , 2001, Human molecular genetics.

[53]  P. Peltomäki,et al.  DNA mismatch repair and cancer. , 2001, Mutation research.

[54]  O. Kronborg,et al.  A new fecal calprotectin test for colorectal neoplasia. Clinical results and comparison with previous method. , 2001, Scandinavian journal of gastroenterology.

[55]  D. Amadori,et al.  Multiple detection of genetic alterations in tumors and stool. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[56]  B. Johne, O. Kronborg, H. I. Tøn, J. Kristinsson,,et al.  A New Fecal Calprotectin Test for Colorectal Neoplasia: Clinical Results and Comparison with Previous Method , 2001 .

[57]  L M Schuman,et al.  The effect of fecal occult-blood screening on the incidence of colorectal cancer. , 2000, The New England journal of medicine.

[58]  S. Thibodeau,et al.  Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel. , 2000, Gastroenterology.

[59]  Schoen Re.  Interrupting the adenoma-carcinoma sequence: screening for adenomas and cancer, now and in the future. , 2000 .

[60]  C. Boland.  Molecular Genetics of Hereditary Nonpolyposis Colorectal Cancer , 2000, Annals of the New York Academy of Sciences.

[61]  J. Rhodes.  Colorectal cancer screening in the UK: Joint Position Statement by the British Society of Gastroenterology, the Royal College of Physicians, and the Association of Coloproctology of Great Britain and Ireland , 2000, Gut.

[62]  S. Kudo,et al.  Early colorectal cancer: Flat or depressed type , 2000, Journal of gastroenterology and hepatology.

[63]  T. Ruers,et al.  New protocol for DNA extraction of stool. , 2000, BioTechniques.

[64]  K. Matsuda,et al.  Involvement of APC and K-ras mutation in non-polypoid colorectal tumorigenesis , 1999, British Journal of Cancer.

[65]  D. Ahlquist,et al.  Morphometric analysis of the "mucocellular layer" overlying colorectal cancer and normal mucosa: relevance to exfoliation and stool screening. , 2000, Human pathology.

[66]  J. Devlin,et al.  Indications for referral and assessment in adultliver transplantation: a clinical guideline , 1999, Gut.

[67]  S. Haga,et al.  Determining the telomerase activity of exfoliated cells in intestinal lavage solution to detect colorectal carcinoma. , 1999, Anticancer research.

[68]  T. Church,et al.  Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. , 1999, Journal of the National Cancer Institute.

[69]  P. Glasziou,et al.  A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, hemoccult. , 1998, BMJ.

[70]  A. Norman,et al.  Kirsten ras mutations in patients with colorectal cancer: the multicenter "RASCAL" study. , 1998, Journal of the National Cancer Institute.

[71]  J. Cummings,et al.  Quantitation of DNA from exfoliated colonocytes isolated from human stool surface as a novel noninvasive screening test for colorectal cancer. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[72]  S. Cummings,et al.  The potential role of fecal carbonic anhydrase II in screening for colorectal cancer. , 1995, The American surgeon.

[73]  J. Olsen,et al.  Randomised study of screening for colorectal cancer with faecal-occult-blood test , 1996, The Lancet.

[74]  K. Kinzler,et al.  Lessons from Hereditary Colorectal Cancer , 1996, Cell.

[75]  T. Kanematsu,et al.  Mutations of the p53 gene in the stool of patients with resectable colorectal cancer , 1996, Cancer.

[76]  A. Zinsmeister,et al.  Fecal marker variability in colorectal cancer: calprotectin versus hemoglobin. , 1995, Scandinavian journal of gastroenterology.

[77]  S. Moss,et al.  Randomised controlled trial of faecal-occult-blood screening for colorectal cancer , 1989, The Lancet.

[78]  K. Suda,et al.  Histopathological studies of superficial‐type early colorectal carcinoma , 1996, Cancer.

[79]  A. Sonnenberg,et al.  Prevention of Colorectal Cancer by Flexible Endoscopy and Polypectomy: A Case-Control Study of 32 702 Veterans , 1995, Annals of Internal Medicine.

[80]  S. Kudo,et al.  p53 immunoreactive stain and early colorectal adenocarcinomas. , 1995, European Journal of Cancer.

[81]  R. Deuter,et al.  A method for preparation of fecal DNA suitable for PCR. , 1995, Nucleic acids research.

[82]  P. Pasricha,et al.  Inhibition of apoptosis during development of colorectal cancer. , 1995, Cancer research.

[83]  G. Cooper,et al.  A national population‐based study of incidence of colorectal cancer and age. Implications for screening in older Americans , 1995, Cancer.

[84]  A. Zauber,et al.  Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. , 1993 .

[85]  L M Schuman,et al.  Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. , 1993, The New England journal of medicine.

[86]  S N Thibodeau,et al.  Microsatellite instability in cancer of the proximal colon. , 1993, Science.

[87]  J. Neoptolemos,et al.  Detection of Colorectal Cancer by Faecal α1-Antitrypsin , 1993 .

[88]  Bert Vogelstein,et al.  APC mutations occur early during colorectal tumorigenesis , 1992, Nature.

[89]  R. Dubrow,et al.  Fecal lysozyme: an unreliable marker for colorectal cancer. , 1992, The American journal of gastroenterology.

[90]  K. Kinzler,et al.  Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. , 1992, Science.

[91]  G. Friedman,et al.  A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. , 1992, The New England journal of medicine.

[92]  I. Hirata,et al.  Immunological determination of fecal hemoglobin and transferrin levels: a comparison with other fecal occult blood tests. , 1992, The American journal of gastroenterology.

[93]  G. Young,et al.  Selecting an Occult Blood Test for Use as a Screening Tool for Large Bowel Cancer , 1991 .

[94]  B. Vogelstein,et al.  A genetic model for colorectal tumorigenesis , 1990, Cell.

[95]  A. Zauber,et al.  The National Polyp Study , 1990 .

[96]  A. Zauber,et al.  The National Polyp Study. Patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomas. , 1990, Gastroenterology.

[97]  D. Ahlquist,et al.  Patterns of occult bleeding in asymptomatic colorectal cancer , 1990, Cancer.

[98]  P. Möller,et al.  Epithelium-specific surface glycoprotein of Mr 34,000 is a widely distributed human carcinoma marker. , 1987, British Journal of Cancer.

[99]  Takurou Nakayama,et al.  ELISA FOR OCCULT FAECAL ALBUMIN , 1987, The Lancet.

[100]  W. Taylor,et al.  Fecal blood levels in health and disease. A study using HemoQuant. , 1985, The New England journal of medicine.

[101]  P. gordon,et al.  The changing distribution of large intestinal cancer , 1982, Diseases of the colon and rectum.

[102]  F. Macrae,et al.  Relationship between patterns of bleeding and Hemoccult sensitivity in patients with colorectal cancers or adenomas. , 1982, Gastroenterology.

[103]  M. Whittaker,et al.  The prognosis after surgical treatment for carcinoma of the rectum , 1976, The British journal of surgery.

[104]  S. Kozuka,et al.  Premalignancy of the mucosal polyp in the large intestine: II. Estimation of the periods required for malignant transformation of mucosal polyps , 1975, Diseases of the colon and rectum.

[105]  T. Muto,et al.  The evolution of cancer of the colon and rectum , 1975, Cancer.

[106]  J. Affeldt,et al.  The feasibility study , 2019, The Information System Consultant’s Handbook.

[107]  M. Lipkin,et al.  CELL PROLIFERATION KINETICS IN THE GASTROINTESTINAL TRACT OF MAN. II. CELL RENEWAL IN STOMACH, ILEUM, COLON, AND RECTUM. , 1963, Gastroenterology.

[108]  M. Lipkin,et al.  CELL PROLIFERATION KINETICS IN THE GASTROINTESTINAL TRACT OF MAN. I. CELL RENEWAL IN COLON AND RECTUM. , 1963, The Journal of clinical investigation.

[109]  J. C. Belisario,et al.  Report on a case of? , 1954, Australian journal of dermatology.

[110]  G. Papanicolaou,et al.  The application of cytology in the diagnosis of cancer of the rectum, sigmoid, and descending colon , 1952, Cancer.

[111]  C. Dukes,et al.  The classification of cancer of the rectum , 1980 .